Bio-Connect
Product image
Product image
Product image

InVivoMAb anti-mouse IL-2

Research Use Only
BE0043-1
Bio X Cell
ApplicationsNeutralisation/Blocking, Other Application
Product group Antibodies
ReactivityMouse
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bio X Cell
  • Product Name
    InVivoMAb anti-mouse IL-2
  • Delivery Days Customer
    7
  • Applications
    Neutralisation/Blocking, Other Application
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    S4B6-1
  • Concentration
    4-11 mg/ml
  • Estimated Purity
    >95%
  • Host
    Rat
  • Isotype
    IgG2a
  • Reactivity
    Mouse
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection. Littwitz-Salomon E et al., 2015 Jul 30, Retrovirology
    Read more
  • GITR intrinsically sustains early type 1 and late follicular helper CD4 T cell accumulation to control a chronic viral infection. Clouthier DL et al., 2015 Jan, PLoS Pathog
    Read more
  • Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context. Baeyens A et al., 2015 Feb 1, J Immunol
    Read more
  • Effector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2. McKinstry KK et al., 2014 Nov 5, Nat Commun
    Read more
  • IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cells. Mizui M et al., 2014 Sep 1, J Immunol
    Read more
  • Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection. Srivastava S et al., 2014 May 5, J Exp Med
    Read more
  • IL-2-dependent adaptive control of NK cell homeostasis. Gasteiger G et al., 2013 Jun 3, J Exp Med
    Read more
  • Cutting Edge: memory regulatory t cells require IL-7 and not IL-2 for their maintenance in peripheral tissues. Gratz IK et al., 2013 May 1, J Immunol
    Read more
  • Differential outcome of IL-2/anti-IL-2 complex therapy on effector and memory CD8+ T cells following vaccination with an adenoviral vector encoding EBV epitopes. Smith C et al., 2011 May 15, J Immunol
    Read more
  • IL-2 complex treatment can protect naive mice from bacterial and viral infection. Hamilton SE et al., 2010 Dec 1, J Immunol
    Read more

Related products

Product image
Product group Antibodies
References
Bio X Cell
  • SizePrice
Product image
Product group Chemicals
Bio X Cell
  • SizePrice